Therefore, like myasthenia gravis, whether there was a correlation between high-frequency RNS and the severity of clinical symptoms in patients with GFPT1-related LG-CMS deserves a further study of high-frequency RNS in a larger sample of CMS patients with GFPT1 mutations from different countries. Here, GFPT1 is linked to myasthenia gravis.